Clinical trials
Phase 1/2 Hypoglycemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 2 |
| 2005 | 2 |
| 2007 | 2 |
| 2009 | 5 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 3 |
| Suspended | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Minnesota | 8 |
| Diva De Leon | 3 |
| Rodolfo Alejandro | 2 |
| Seraxis | 2 |
| Bows Pharmaceuticals AG | 1 |
| Camillo Ricordi and Jay Skyler | 1 |
| City of Hope Medical Center | 1 |
| Eledon Pharmaceuticals | 1 |
| EndoCell Therapeutics, Inc. | 1 |
| Nambudripad's Allergy Research Foundation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoglycemia | 25 |
| Diabetes Mellitus, Type 1 | 18 |
| Diabetes Mellitus | 10 |
| Hyperglycemia | 4 |
| Autoimmune Diseases | 3 |
| Congenital Hyperinsulinism | 3 |
| Glucose Metabolism Disorders | 3 |
| Hyperinsulinism | 3 |
| Metabolic Diseases | 3 |
| Endocrine System Diseases | 2 |
Trials
Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.